Search
for
Sort by
Research 121–150 of 287
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Modern Management Approaches for Alopecia Areata
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Non-hemorrhage-related adverse effects of rivaroxaban
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative)
- Allopregnanolone and Induction of Endogenous Opioid Inhibition of Oxytocin Responses to Immune Stress in Pregnant Rats
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Green Chemistry in the Pharmaceutical Industry
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Alopecia areata and the gut—the link opens up for novel therapeutic interventions
- Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Single‐port Endoscopic Removal of Forehead Osteoma: An Otolaryngologist's Procedure
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- AB0987 ANIFROLUMAB TREATMENT IMPROVES QUALITY OF LIFE AND DECREASES SYSTEMIC CORTICOSTEROID USE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Novel investigational drugs for alopecia areata and future perspectives
- Low-dose oral minoxidil improves hair length and global hair density in short anagen syndrome
- An evaluation of the available pharmacotherapy for the treatment of hirsutism
- Non‐invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS‐COV‐2 infection in adult and children
- Med Check